TCT-318 Trans-lesional FFRCT gradient correlates with measured FFR gradient in vessels with serial coronary stenosis: role in stenting strategy  by Tanaka, Kentaro et al.
Ratio of Maximum Coronary Flow Reserve in Response to
Adenosine Compared to Baseline Coronary Flow Reserve
Ratio of Maximum Coronary Blood Flow in
Response to Acetylcholine Compared to
Baseline Coronary Blood Flow
Abnormal Ratio
(2.5)
Normal Ratio
(>2.5)
Abnormal Ratio (£1.5) Coronary ﬂow
reserve: 2.3 (2.1-
2.4)
Coronary ﬂow
reserve: 3.0 (2.8-
3.5)
Coronary blood
ﬂow: 0.9 (0.6-
1.2)
Coronary blood
ﬂow: 1.0 (0.7-0.8)
n¼268 n¼478
Normal Ratio (>1.5) Coronary ﬂow
reserve: 2.2 (2.0-
2.4)
Coronary ﬂow
reserve: 3.2 (2.9-
3.7)
Coronary blood
ﬂow: 2.0 (1.7-
2.1)
Coronary blood
ﬂow: 2.2 (1.8-2.8)
n¼173 n¼520
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMTCT-315
Invasively Derived Coronary Flow Capacity: Prognostic Implications of a Cross-
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Background: Either coronary ﬂow reserve (CFR) or fractional ﬂow reserve (FFR) can
sufﬁce for diagnosis of signiﬁcant coronary stenoses, but they can over- or underes-
timate severity in many cases. An alternative approach is the coronary ﬂow capacity
(CFC) concept, originally derived from PET-imaging, which integrates CFR and
hyperemic ﬂow (hAPV) to depict the ischemic burden of the myocardium. We studied
the prognostic implications of addition of hAPV to CFR within the CFC concept
derived from invasive measurements.
Methods: Coronary pressure and ﬂow velocity were measured in 154 patients in whom
revascularization was deferred in the pre-FAME era. The additive value of hAPV to CFR
was tested with the net reclassiﬁcation index (NRI), integral discrimination improvement
(IDI) and relative IDI. After stratiﬁcation in normal, mildly reduced, moderately reduced,
and severely reduced CFC, using literature-derived CFR cut-offs and the corresponding
hAPV percentiles, event rates up to 10-years follow-up were estimated with the Kaplan
Meier method, and a Cox proportional hazards model was used to test the association of
CFC with MACE, adjusting for confounding variables (p< 0.1).
Results: Median follow-up was 11.9 years (10.0 – 13.4 years). CFR was signiﬁcantly
associated with MACE (p< 0.001). The addition of hAPV to CFR yielded an NRI of 0.49
(Standarderror (SE) 0.17, p¼0.003), IDI of 0.024 (SE0.012,p¼0.04), and rIDI of 43.3%. In
contrast, addition of FFR to CFR did not improve discrimination. KM-estimates of MACE
across the CFC categories showed a signiﬁcant linear trend at all time-points (P< 0.001),
withMACE increasingwith increasing impairment ofCFC.After adjusting for confounding
variables,CFCwasstrongly associatedwith long-termMACE: comparedwithnormalCFC,
a mildly and moderately reduced CFC were associated with a 1.9-fold (95% CI: 1.0 – 3.4,
p¼0.040), and a 2.8-fold (95% CI: 1.2 – 6.2, p¼0.013) increase in MACE, respectively.
Conclusions: The addition of hAPV to CFR in the CFC concept improves its the
discriminative value for MACE. CFC may provide a disruptive physiological concept,
applicable to all diagnostic modalities that measure ﬂow.
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Background: Microvascular dysfunction has been associated with increased mor-
tality. However, little is known whether physiologic microcirculatory indices can
fundamentally be affected by coronary dimensions.
Methods: Volumetric IVUS (50 mm length) and physiologic assessment (Fractional
Flow Reserve [FFR], Coronary Flow Reserve [CFR], and Index of Microcirculatory
Resistance [IMR]) in the LAD artery were performed in 122 patients with non-
obstructed epicardial arteries. Coronary ﬂow was assessed with a thermo-dilution
method by obtaining mean transit time (Tmn: an inverse correlate to absolute ﬂow) at
rest and hyperemia. IMR was measured as distal coronary pressure x hyperemic Tmn.JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/FFResults: No patient had signiﬁcant stenosis in LAD (FFR: 0.870.04, %plaque
volume: 26.19.0%). Resting Tmn positively correlated with vessel and lumen vol-
umes (p< 0.01, p¼0.04), whereas hyperemic Tmn showed no correlation with the
artery size. As a result, IMR was unrelated to any IVUS indices, while CFR positively
correlated with the artery size (p< 0.001 for both vessel and lumen). With micro-
vascular dysfunction deﬁned as IMR 25, ROC analysis determined CFR¼3.75 as
the best cutoff. Discordance of reduced CFR with normal IMR was seen in patients
with smaller artery size, leading to shorter resting Tmn, despite the equivalent %
plaque volume and hyperemic Tmn (Figure).Conclusions: Small coronary size may increase resting coronary ﬂow, reducing CFR
even in the absence of epicardial stenosis and microvascular dysfunction. Potential
impact of artery size should be noted in interpretation of physiologic indices using
resting ﬂow status.
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Background: In the absence of clear-cut indications for provocative test (PT), cor-
onary artery spasm (CAS) may be underdiagnosed whereas the widespread use of
early coronary angiography has found that acute ischemic syndromes are not always
related to atherosclerotis. The objective of the present study was to evaluate the
incidence of CAS in a population of patients with chest pain who underwent meth-
ylergonovine-based PT.
Methods: The present study is a retrospective analysis from an University tertiary care
hospital where a policy of systematic detection of CAS by PT is applied in patients
with chest pain at rest and without signiﬁcant coronary stenosis. PT complications
include death, MI, stroke, delayed or resistant CAS, ventricular ﬁbrillation, and acute
atrio ventricular block.
Results: During a 10-year period (2002-2012), a total of 18,454 angiographies were
performed. CAS was documented in 256 (10.7%) of the 2,397 patients with normal or
near normal coronary arteries and chest pain who underwent PT. Compared to the
overall population, CAS patients were more often female (44.7% vs. 29.6%; p<
0.0001), younger (55 [47.5-64] years vs. 61 [52-70] years; p¼0.0001), and smokers
(63.7% vs. 42.3%; p< 0.0001). Initial presentation was more frequently acute coro-
nary syndrome (36.7% vs. 29.1%) or non-speciﬁc chest pain (46% vs. 21.9%). The
rate of complications after PT was 0.9% (n¼23). Complications included delayed or
persistant CAS (0.3%), VF/asystoly/AVB (0.3%), transient ischemic attack (0.2%),
and non Q wave MI (0.04%). Urgent coronary stenting was required to restore arterial
patency in three patients with persistant CAS.
Conclusions: This retrospective study of 10 years of experience suggests that CAS is
present in 10.7% of patients with myocardial ischemia symptoms at rest and without
signiﬁcant coronary stenosis. Methylergonovine based PT appear to be extremly safe
when performed in selected patients with normal or near normal coronary arteries.
These ﬁndings could justify performing PT more systematically in this setting to avoid
the potentially severe outcomes of undiagnosed CAS.
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Background: Fractional ﬂow reserve derived from coronary CT (FFRct) has high
diagnostic accuracy compared to FFRcath, and modulation of the FFRct with “virtualR and Physiologic Lesion Assessment B91
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comstenting” is feasible for predicting the effect of PCI. However, the validity of FFRct
along the length of a vessel compared with FFRcath is unknown. The purpose of this
study is to compare trans-lesional FFRcath vs. FFRct gradients in vessels with serial
stenoses.
Methods: 18 patients with stable coronary artery disease had pull-back FFRcath
measurements across the serial lesions. In each patient FFRct was performed utilizing
pre-cath cCTA data. Blinded comparisons of FFRcath and FFRct at co-registered
points were performed. Computational models were then modiﬁed to simulate virtual
stenting strategy of the proximal, distal or both lesions.
Results: 18 vessels were assessed, with ischemia (FFRcath 0.80) present in 13
(72.2%). Each patient had 2 or more angiographic stenoses >30% with trans-lesional
FFRcath gradient of 0.100.09. The correlation between FFRcath and FFRct gradient
was r¼0.92, p< 0.001. Virtual stenting demonstrated a wide range of scenarios with
the need for one or two stents for relief of the ischemia. Figure 1 exempliﬁes a case in
which stenting of each single lesion did not result in FFRct >0.8. Virtual stenting of
both stenoses relieved the ischemia with ﬁnal FFRct ¼ 0.84.
Conclusions: Trans-lesional FFRct gradient correlates closely with FFRcath
gradient in vessels with serial stenoses. This is a core foundation for the potential
usefulness of computational modeling to evaluate and plan treatment of complex
and serial stenoses.TCT-319
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Background: The instant wave-free ratio (iFR) and fractional ﬂow reserve (FFR) are
indices of coronary disease severity which use pressure as a measure of lesion sig-
niﬁcance. The aim of this study was to quantify iFR and FFR’s individual ability to
detect ischaemia and ﬂow limitation against multiple perfusion modalities.
Methods: Pooled analysis of data using a random effect model. 4 studies which
compared iFR and FFR against the following perfusion modalities were included:
SPECT scintigraphy, positron emission tomography (H215O PET), hyperaemic ste-
nosis resistance (HSR) and coronary ﬂow reserve (CFR). In total, 265 stenoses in 220
patients were evaluated. The performance of iFR and FFR to detect ischaemia or ﬂow
limitation was compared using the area under the ROC curve (AUCROC).B92 JACC Vol 64/11/Suppl B j SeptemberResults: Baseline iFR and hyperaemic FFR demonstrated equal overall agreement
with methods of perfusion (iFR AUCROC¼0.88, FFR AUCROC¼0.88) (Figure).
When non-invasive perfusion methods were used as reference standards, iFR was non-
inferior to FFR (iFR-SPECT AUCROC¼0.84 vs FFR-SPECT AUCROC¼0.88,
p>0.2; iFR-PET AUCROC¼0.85, FFR-PET AUCROC¼0.86, p>0.2). When inva-
sive ﬂow indices were used as reference comparisons, iFR was non-inferior (iFR-HSR
AUCROC¼0.95 vs FFR-HSR AUCROC¼0.97, p>0.3) or superior to FFR (iFR-CFR
AUCROC ¼ 0.82 vs FFR-CFR AUCROC¼0.72, p< 0.01) to detect ﬂow limitation.Conclusions: iFR and FFR are equally able to detect ischaemia and ﬂow limitation,
against multiple perfusion modalities. Studies with hard clinical endpoints will eval-
uate whether the non-inferiority of iFR will translate into favourable clinical
outcomes.
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Background: To compare the clinical outcomes of fractional ﬂow reserve (FFR)
guided percutaneous coronary intervention (PCI) versus coronary artery bypass
grafting (CABG) in left main or triple vessel disease.
Methods: Between January 2008 and December 2011, a total of 1515 patients with
signiﬁcant left main or triple vessel disease received FFR guided PCI (N¼250) or
CABG (N¼1265). Primary endpoint was the composite of death from any cause,
myocardial infarction (MI), stroke, or repeated revascularization (MACCE) at 1 year.
Results: At 1 year follow-up, MACCE occurred 12 (4.8%) in FFR guided PCI group
and 61 (4.8%) in CABG group (P¼0.97). The rate of death were similar between
groups (3 [1.2%] vs. 37 [2.9%], P¼0.12). The rate of the composite of death, MI or
stroke was signiﬁcantly lower in FFF-guided PCI group (3 [1.2%] vs. 51 [4.0%],
P¼0.029). The rate of repeated revascularization was signiﬁcantly lower in CABG
group (9 [3.6%] vs. 13 [1.0%], P¼0.002). After adjustment, the risk of MACCE at 1
year was not signiﬁcantly different between groups (hazard ratio [HR] 0.99, 95%
conﬁdence interval [CI] 0.54-1.85, p¼0.99). The risk of death was not signiﬁcantly
different (HR 0.40, 95% CI 0.14-1.34, P¼0.13). The risk of the composite of death,
MI, or stroke was signiﬁcantly lower in FFR guided PCI group (HR 0.30, 95% CI
0.09-0.96, P¼0.042) and the risk of repeated revascularization was signiﬁcantly lower
in CABG group (HR 3.18, 95% CI 1.35-7.50, P¼0.008).13–17, 2014 j TCT Abstracts/FFR and Physiologic Lesion Assessment
